파이프라인
파이프라인
| Product | Target | Indication |
Clinical Site |
Pre | Phase 1 | Phase 2 | Phase 3 |
|---|---|---|---|---|---|---|---|
| Vactosertib |
TGF-β1 -signaling |
Osteosarcoma (monotherapy) |
US KOR |
|
|||
|
mCRC, NSCLC, r/rMM, Desmoid etc. (Combination strategy) |
US KOR |
|
|||||
| MP010 | TME | Solid Tumors | - |
|
|||
| MP2021 | TM4SF19 |
Osteoporosis, Arthritis, Bone metastatic disease |
- |
|
|||
| Category | Product | Target | Indication | Clinical Sites | Preclinical | Phase 1 | Phase 2 | Phase 3 |
|---|---|---|---|---|---|---|---|---|
| Oncology | Vactosertib |
TGF-β1 -signaling |
Osteosarcoma (monotherapy) |
US KOR |
US FDA ODD, RPDD, FTD and EU OMPD
|
|||
|
mCRC, NSCLC, r/rMM, Desmoid etc. (Combination strategy) |
US KOR |
Exploring indication expansion
|
||||||
| MP010 | TME | Solid Tumors | - |
|
||||
|
Healthy Aging |
MP2021 | TM4SF19 |
Osteoporosis, Arthritis, Bone metastatic disease |
- |
|
|||